Dexcom Reports Second Quarter 2026 Financial Results

What was reported

SAN DIEGO - (BUSINESS WIRE-July 30, 2026) - DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2026.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 30, 2026 · Open the source ↗

What the evidence supports

Dexcom published its results for the period in a press release furnished to the SEC (Form 8-K, Item 2.02).

What remains unknown

Audit status of the figures (results furnished on Form 8-K or 6-K are typically unaudited), and anything about future periods. Any outlook is the company's own projection. Figures and claims are the company's own description and have not been independently verified.

Figures as stated

Numbers exactly as written in the source. We don’t annualise, convert or add them up.

Source passages

Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.

Press release headlineDexcom Reports Second Quarter 2026 Financial ResultsU.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 30, 2026 · Open the source ↗

Press release lead paragraphSAN DIEGO - (BUSINESS WIRE-July 30, 2026) - DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2026.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 30, 2026 · Open the source ↗

Amount stated in press release•Revenue grew 13% year-over-year to $1.308 billion on a reported basis and 12% year-over-year on an organic1 basis.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 30, 2026 · Open the source ↗

Revision history

1. Revision 1 · Oct 28, 2026, 20:53 UTC

   Dexcom Reports Second Quarter 2026 Financial Results

Spotted an error? Tell us. Corrections are published, never silent: see all corrections.